Neuphoria Therapeutics Inc. Common Stock (NEUP) is a publicly traded Healthcare sector company. As of July 2, 2026, NEUP trades at $3.56 with a market cap of $23.62M and a P/E ratio of -17.89. NEUP moved -19.91% today. Year to date, NEUP is -7.07%; over the trailing twelve months it is -49.43%. Its 52-week range spans $2.90 to $21.40. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces NEUP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NEUP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NEUP recently traded at $3.56. Market cap is $23.62M. P/E ratio is -17.89. Revenue is $15.65M.
| Metric | Value |
|---|---|
| Price | $3.56 |
| Market Cap | $23.62M |
| P/E Ratio | -17.89 |
| EPS | $-0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $21.40 |
| 52-Week Low | $2.90 |
| Volume | 634.48K |
| Avg Volume | 0 |
| Revenue (TTM) | $15.65M |
| Net Income | $-369.63K |
| Gross Margin | 0.00% |
1 analysts cover NEUP: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.